ClinicalTrials.gov
public full text
Public Domain
Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD
1. To determine if catheter-based atrial fibrillation (AF) ablation is superior to Amiodarone treatment for symptomatic persistent/permanent AF in ICD/CRTD patients with an impaired left ventricular function. 2. Hypothesis: AF ablation is better than Amiodarone for subjects with symptomatic persistent or permanent AF and impaired LV function in terms of recurrence of AF, quality of life, 6-minute walk distance, EF and total number of hospitalizations.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter#890549
- Fluid Management in Patients Undergoing Cardiac Surgery#848030
- Differential Impact of Catheter Ablation Across Heart Failure Phenotypes in Atrial Fibrillation: A Grade Assessed Systematic Review and Meta-Analysis#1252574
- The Clinical and Biochemical Effects of Atrial Fibrillation on Heart Failure with Reduced Ejection Fraction#1055868
- Swiss Atrial Fibrillation Cohort Study#1211890
Record · ID 1229194
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive